No.44
No.43
No.42
No.41
No.40
No.39
No.38
No.37
No.36
No.35
No.34
No.33
No.32
No.31
No.30
No.29
No.28
No.27
No.26
No.25
No.24
No.23
No.22
No.21
Cannabis World Journals (CWJ), is a digital magazine focused on the most relevant changes happening in the cannabis industry worldwide. It provides insights of legal experts in the cannabis industry’s regulations, business tips to entrepreneurs, investors, and participants. In addition, it seeks to educate medical personnel and scientific researchers as well passionate growers. We want to drive people’s attention to the most updated content in the cannabis world.
Cannabis World Journals
The Power Is in Texas
The Voices of cannabis in Houston • Will the green wave be able to stay in Texas for good? What will the outlook be like for Texas regarding cannabis decriminalization after the election?
Taste of Texas Hemp Cup
Texascbdfair
Why in the USA Hemp Is More Widely Accepted for Production than Psychoactive Cannabis?
In the Expert’s Room-Special Edition: Texas Hemp Growers Association • Hemp had not been widely grown in Texas for 80 years, and although the Texas Department of Agriculture granted three licenses in 2020, some growers chose to abstain and see how others fared.
UNITED STATES: Is Texas the Most Restrictive State? • Kentuckians are leaving the state to access medical cannabis where it is legal and unfortunately cannot return to their home turf as they would be considered criminals
GREEN WAVE FOR TEXAS IN 2022 • The legalization of hemp was crucial in the decline of cannabis arrests, prosecutions and convictions, as it concentrated prosecutorial efforts on drugs that do pose a danger and have a real impact on crime rates.
Texas: Cannabis Legality Before and After the Election • Will the situation in Texas ever change for the plant? How do the cannabis laws remain in the state?
Interview with Jesce Horton, CEO at LOWD
The Promising Market of Medical Cannabis in Texas • In the state of Texas, medical cannabis patients can access the drug through the Compassionate Use Program (CUP) which initially only contemplated the use of cannabis in patients with intractable epilepsy, later this law was expanded and currently, the program is open to patients with the following conditions: seizure disorders, multiple sclerosis, spasticity, amyotrophic lateral sclerosis, autism, cancer, PTSD, and incurable neurodegenerative disease.
The Texas Cannabis Market: Beyond Dispensaries • As the market matures and customers become more conscious of their consumption, companies must expect value-added products to gain market share.
Pro-Nano-Liposphere Technology: a Booster for CBD Uptake • Currently, CBD (cannabidiol) based medications can only be prescribed for people suffering from cancer, autism, epilepsy, multiple sclerosis, posttraumatic stress disorder, and neurodegenerative diseases.
Neglecting THC as a Medical Cannabinoid • THC is a potent anti-inflammatory, analgesic, anxiolytic, antiemetic, antitumor, and antioxidant that has been effective in the treatment of neuropathic pain, epilepsy, anxiety, chemotherapy-related nausea, and multiple sclerosis.